Introduction

Colorectal cancer is one of the most commonly diagnosed cancers and a leading cause of cancer-related death. Screening for colorectal cancer is likely to improve the odds of detecting cancer at an early stage, reducing mortality.

Earlier commercially available Fecal Occult Blood tests utilized a guaiac test, requiring special dietary restrictions to minimize false positive and false negative results. CoproHemoGnost Test Panel is designed especially to detect human hemoglobin in fecal samples using immunochemical methods, improving specificity for the detection of lower gastrointestinal disorders, including colorectal cancers and adenomas, without the need for dietary restrictions.